ISSN: 2161-0460

Jornal da doença de Alzheimer e parkinsonismo

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Indexado em
  • Índice Copérnico
  • Google Scholar
  • Sherpa Romeu
  • Abra o portão J
  • Genâmica JournalSeek
  • Chaves Acadêmicas
  • JornalTOCs
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • Biblioteca de Periódicos Eletrônicos
  • RefSeek
  • Universidade Hamdard
  • EBSCO AZ
  • OCLC – WorldCat
  • Catálogo online SWB
  • Biblioteca Virtual de Biologia (vifabio)
  • Publons
  • Fundação de Genebra para Educação e Pesquisa Médica
  • Euro Pub
  • ICMJE
Compartilhe esta página

Abstrato

Toll-Like Receptor Signaling in Alzheimer's Disease Progression

Eric J Downer

Evidence continues to underpin the role of the innate immune system in pathologies associated with neuroinflammation. Neuroinflammation is the complex innate immune response of neural tissue to control infection, and Toll-like receptors (TLRs), a major family of pattern recognition receptors (PRRs) that mediate innate immunity, have emerged as players in Alzheimer’s disease (AD). Upon ligation with their ligand, TLRs induce signaling involving recruitment of various adaptors and signaling molecules that culminate in the activation of genes including interferons and cytokines. TLR expression has been identified on resident central nervous system cells including microglia and neurons, with an altered expression profile for this receptor determined in microglia from AD patients. Furthermore, TLR activation on microglia is associated with amyloid-β (Aβ) clearance from the brain, suggesting that modulation of TLR signaling may be a therapeutic strategy for plaque removal. This review will highlight evidence linking the TLR system with the progression of AD, assessing TLR involvement in events associated with AD in cellular systems, transgenic murine models of AD and in humans.